George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPATH.L Regulatory News (PATH)

  • There is currently no data for PATH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Termination of DTU Acquisition

15 Feb 2021 14:00

RNS Number : 1470P
Path Investments plc
15 February 2021
 

15 February 2021

Path Investments plc

("Path" or the "Company")

Termination of DTU Acquisition and Restoration of Trading

 

 

Path Investments plc (TIDM: PATH), the energy and natural resources investment company, announces the termination of the proposed transaction to acquire DT Ultravert ("DTU"), a technology used in the energy industry, from two vendors, including Zoetic International plc ("Zoetic") (the "Transaction").

 

As previously announced, completion of the Transaction was subject, inter alia, to the publication of a prospectus by Path prepared in accordance with the Prospectus Regulation Rules made under section 73A of the Financial Services and Markets Act 2000 (as amended) and approved by the UK Financial Conduct Authority ("FCA") under section 87A of Financial Services and Markets Act 2000 (as amended) and re-admission of the Company's shares to trading on the Main Market of the London Stock Exchange. Concerns raised regarding the Transaction during the preparation of the prospectus and also recent press speculation brought to the Board's attention concerning Zoetic have led the Board to question the merits of continuing with the Transaction as they consider it may pose unnecessary risk to the Company and its shareholders. As a result, the Board has terminated the Transaction with immediate effect.

 

Path has been undertaking market soundings (as defined in MAR) in connection with an equity fundraise to support its continuing investment strategy (as outlined in the Company's prospectus published in March 2017), together with the proposed acquisition of DTU. This was only a small part of the Company's overall strategy to acquire energy assets and the Directors remain focussed on pursuing opportunities in line with the Company's investment strategy. It remains the Company's intention to complete a fundraise for what is currently anticipated to be a gross amount of approximately £2 million in the form of equity to allow it to meet its working capital requirements and further its investing strategy. However, there is currently no certainty of the structure, quantum or that the fundraise will be completed. The proposed fundraise would require the publication of a prospectus as more than 20% of its existing ordinary share capital would be issued and admitted to trading. This is currently being prepared, and further announcements will be made as appropriate in due course.

 

Restoration of Trading

 

Following the termination of the Transaction, it is expected that Path's ordinary shares will resume trading on the Main Market of the London Stock Exchange in due course following consultation with the FCA.

 

This announcement contains inside information for the purposes of Article 7 of Regulation (EU) 596/2014 which is part of UK law by virtue of the European Union (Withdrawal) Act 2018. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

 

For further information please contact:

Path Investments plc

C/O IFC

Christopher Theis

 

Jack Allardyce

 

 

 

IFC Advisory (Financial PR & IR)

020 3934 6630

Tim Metcalfe

 

Zach Cohen

 

 

 

Grant Thornton UK LLP (Financial Adviser)

 

Jamie Barklem

 

Samantha Harrison

 

Harrison Clarke

020 7383 5100

 

 

 

Keith, Bayley, Rogers & Co. Limited (Broker)

 

Brinsley Holman

07776 30 22 28

Graham Atthill-Beck

07506 43 41 07

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCTAMJTMTIBBLB
Date   Source Headline
7th Apr 20227:00 amRNSUpdate on Acquisition
5th Apr 20227:00 amRNSInvestor Presentation
1st Apr 20222:45 pmRNSResult of General Meeting
14th Mar 20221:09 pmRNSPublication of Prospectus, Notice of GM, Fundraise
1st Feb 20227:00 amRNSProposed Transaction Update
31st Dec 20217:00 amRNSProposed Transaction Update
18th Nov 20217:00 amRNSAppointment of Joint Broker
26th Oct 20217:00 amRNSProposed Transaction Update
13th Oct 20216:02 pmRNSCorrection: Holding(s) in Company
13th Oct 20214:52 pmRNSHolding(s) in Company
11th Oct 20217:00 amRNSBlock listing Interim Review
29th Sep 20217:00 amRNSInterim Results for the six months to 30 June 2021
28th Sep 20212:45 pmRNSResult of AGM
22nd Sep 20212:41 pmRNSFurther secured loan provided to DG Innovate
9th Sep 20216:01 pmRNSHolding(s) in Company
2nd Sep 20217:00 amRNSNotice of AGM
18th Aug 202111:54 amRNSCorrection: Holding(s) in Company
18th Aug 20217:00 amRNSHolding(s) in Company
13th Aug 20217:45 amRNSProposed Acquisition of DG Innovate & Suspension
14th Jul 20215:23 pmRNSHolding(s) in Company
14th Jul 20212:39 pmRNSHolding(s) in Company
24th Jun 20217:00 amRNSFinal Results for the Year Ended 31 December 2020
16th Jun 20217:00 amRNSHolding(s) in Company
8th Jun 202111:49 amRNSHolding(s) in Company
7th Jun 202112:04 pmRNSHolding(s) in Company
9th Apr 202110:03 amRNSHolding(s) in Company
9th Apr 20217:00 amRNSBlock Listing
1st Apr 20215:02 pmRNSHolding(s) in Company
31st Mar 20219:55 amRNSTotal Voting Rights
24th Mar 20212:06 pmRNSDirector/PDMR Share Transaction
19th Mar 20218:53 amRNSHolding(s) in Company
12th Mar 20215:36 pmRNSAdmission of previously issued shares
12th Mar 202112:50 pmRNSPublication of Prospectus
8th Mar 202111:05 amRNSSecond Price Monitoring Extn
8th Mar 202111:00 amRNSPrice Monitoring Extension
1st Mar 20214:41 pmRNSSecond Price Monitoring Extn
1st Mar 20214:36 pmRNSPrice Monitoring Extension
26th Feb 20212:06 pmRNSSecond Price Monitoring Extn
26th Feb 20212:00 pmRNSPrice Monitoring Extension
26th Feb 20217:00 amRNSEquity Fundraise Update
19th Feb 20217:00 amRNS£3.5 million Equity Fundraise
15th Feb 20212:00 pmRNSTermination of DTU Acquisition
3rd Dec 20209:44 amRNSSubscription for £55,000 of Convertible Loan Stock
5th Nov 20207:00 amRNSFurther re the Acquisition of 75% of DT Ultravert
8th Oct 20209:55 amRNSOption Surrender and Issue of Replacement Options
5th Oct 20207:00 amRNSProposed sale of Kansas Land Leases and equipment
1st Oct 202011:41 amRNSFurther re the Acquisition of DT Ultravert
30th Sep 20207:00 amRNSBoard Changes & Acquisition of Deferred Shares
10th Sep 20201:30 pmRNSInterim Results for the six months to 30 June 2020
10th Sep 20201:15 pmRNSFinal Results for the Year Ended 31 December 2019

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.